Compare Johnson & Johnson (JNJ) vs Lennar Corporation (LEN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Johnson & Johnson vs Lennar Corporation — how do they compare? Johnson & Johnson trades at $259 (market cap $626.09B), while Lennar Corporation trades at $87.37 (market cap $21.05B). The key difference: Johnson & Johnson is far larger — about 29.7× Lennar Corporation's market cap, and Lennar Corporation pays the higher dividend (2.28%). Which is the better fit depends on your goals.
| JNJ | LEN | |
|---|---|---|
Market Cap | $626.09B | $21.05B |
Volume | 6,156,228 | — |
Sector | Health | Consumer Cyclical |
52-Week High | $267.24 | $142.40 |
52-Week Low | $172.78 | $81.84 |
Enterprise Value | $654.37B | $24.93B |
Dividend Yield | 2.06% | 2.28% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →About Lennar Corporation
Lennar is the second-largest public homebuilder in the United States. The company's homebuilding operations target first-time, move-up, and active adult homebuyers mainly under the Lennar brand name. Lennar's financial-services segment provides mortgage financing and related services to its homebuyers. Miami-based Lennar is also involved in multifamily construction and has invested in numerous housing-related technology startups.
Read more on LEN →
